Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 3
1982 1
1983 1
1984 2
1985 3
1986 2
1987 6
1988 8
1989 5
1990 8
1991 4
1992 8
1993 8
1994 17
1995 14
1996 11
1997 5
1998 19
1999 6
2000 17
2001 13
2002 9
2003 3
2004 5
2005 4
2006 3
2007 2
2008 4
2009 3
2010 1
2012 1
2015 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

198 results

Results by year

Filters applied: . Clear all
Page 1
Drug discovery in the next millennium.
Ohlstein EH, Ruffolo RR Jr, Elliott JD. Ohlstein EH, et al. Annu Rev Pharmacol Toxicol. 2000;40:177-91. doi: 10.1146/annurev.pharmtox.40.1.177. Annu Rev Pharmacol Toxicol. 2000. PMID: 10836132 Review.
New strategies in drug discovery.
Ohlstein EH, Johnson AG, Elliott JD, Romanic AM. Ohlstein EH, et al. Methods Mol Biol. 2006;316:1-11. doi: 10.1385/1-59259-964-8:1. Methods Mol Biol. 2006. PMID: 16671397 Free PMC article. Review.
Endothelin receptor antagonists.
Elliott JD, Ohlstein EH, Peishoff CE, Ellens HM, Lago MA. Elliott JD, et al. Among authors: ohlstein eh. Pharm Biotechnol. 1998;11:113-29. doi: 10.1007/0-306-47384-4_6. Pharm Biotechnol. 1998. PMID: 9760678 Review. No abstract available.
Therapeutic modulation of transcription factor activity.
Emery JG, Ohlstein EH, Jaye M. Emery JG, et al. Among authors: ohlstein eh. Trends Pharmacol Sci. 2001 May;22(5):233-40. doi: 10.1016/s0165-6147(00)01661-8. Trends Pharmacol Sci. 2001. PMID: 11339974 Review.
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia.
Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, Badger AM, Legos JJ, Erhardt JA, Ohlstein EH, Hunter AJ, Harrison DC, Philpott K, Smith BR, Adams JL, Parsons AA. Barone FC, et al. Among authors: ohlstein eh. Med Res Rev. 2001 Mar;21(2):129-45. doi: 10.1002/1098-1128(200103)21:2<129::aid-med1003>3.0.co;2-h. Med Res Rev. 2001. PMID: 11223862 Review.
198 results